Objective To review the current status of practical knowledge related to insulin-associated
lipohypertrophy (LH)—an accumulation of fatty subcutaneous nodules commonly caused by …

Background: Lipohypertrophy is a common complication in patients with diabetes receiving
insulin therapy. There is a lack of consensus regarding how much lipohypertrophy affects …

Abstract Introduction Lipohypertrophies (LHs) due to incorrect insulin injection techniques
have been described in the literature for decades. Their rate averages 38%, but this is still …

Glycemic variability remains frequent in patients with type 1 diabetes treated with insulin
pumps. Heterogeneous spreads of insulin infused by pump in the subcutaneous (SC) tissue …

Background. Lipohypertrophy (LH) of subcutaneous tissue is an insulin‐induced
complication occurring in patients with diabetes. We aimed to define the prevalence of LH …

Introduction Lipohypertrophy is a common complication of exposure to insulin therapy.
Despite the prevalence of lipohypertrophy and its potentially hazardous effects on glucose …

Introduction Insulin, which is used in the treatment of diabetes mellitus (DM), may lead to the
development of lipohypertrophy (LH) which can negatively affect the management of …

Introduction Proper insulin injection technique is important for optimal glycaemic control, yet
patients with diabetes often inject insulin incorrectly. Previous studies identified common …

Background: It is important that physicians be aware of LH. We designed a questionnaire to
determine physician awareness, knowledge, and behaviors regarding LH in clinical …

Aims Subclinical lipohypertrophy is a lesion meeting ultrasonic criteria for lipohypertrophy
that was not detected by inspection and palpation. Little information is published on …